comparemela.com
Home
Live Updates
REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator : comparemela.com
REPEAT/Organon & Samsung Bioepis Announce US Launch of HUMIRA Biosimilar HADLIMA™ (adalimumab-bwwd) in Multiple Presentations Consistent with Originator
JERSEY CITY, N.J. & INCHEON, Korea--(BUSINESS WIRE)--Jul 5, 2023--
Related Keywords
Jersey ,
United States ,
New Jersey ,
Jersey City ,
Kevin Ali ,
Anna Nayun Kim ,
Jane Chung ,
Christopher Hansung Ko ,
Samsung Bioepis ,
Linkedin ,
Samsung Bioepis Co Ltd ,
Twitter ,
Patient Support Program ,
Instagram ,
Arthritis Foundation ,
Exchange Commission ,
Intuitive Design Applied Research Institute ,
Arthritis Foundation Ease Of Use Certification ,
Organon Co ,
Pushtouch Autoinjector Close Up ,
Business Wire ,
Chief Executive Officer ,
Option Recognized ,
Use Certification ,
Idiopathic Arthritis ,
Prescribing Information ,
Boxed Warning ,
Medication Guide ,
Organon Samsung Bioepis ,
Organon Logo ,
Securities Litigation Reform Act ,
Annual Report ,
Media Contacts ,
Nayun Kim ,
comparemela.com © 2020. All Rights Reserved.